Journal of Clinical Gastroenterology and Hepatology Open Access

  • ISSN: 2575-7733
  • Journal h-index: 5
  • Journal CiteScore: 0.63
  • Journal Impact Factor: 0.41
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +32 25889658

Role of mini gastric bypass/OAGB in thin diabetics: new programme in Serbia (AP Vojvodina)

6th Annual European Conference on Gastroenterology
June 19-20, 2018 Paris, France

Miroslav D Ilic

University of Novi Sad, Serbia

Keynote: J Clin Gastroenterol Hepatol

Abstract:

Aim: The aim of this study is to investigate a role of surgeon in treatment of diabetes mellitus type 2 (DMT2) and adequate metabolic procedure, especially mini gastric bypass (MGB/OAGB) and initial results in autonomous province of Vojvodina (Serbia), with highest European incidence and mortality. Methods: We searched literature data and looked how is adequate for conservative treatment of DMT2 in capital of Vojvodina, Novi Sad. Results: MGB/OAGB is most effective operation in thin diabetics. Duration of remission DMT2 are long standing up to 7 years in around 90% of patients. We operated 8 patients for two years who were thin insulin dependent diabetics, with complete remission and stop of insulin after 7 days. Conclusion: Surgeons were involved in treating DMT2 from ancient time till today. From 2015/16 modern guidelines recognize a important role of surgery in treatment of DMT2. Obesity paradox warning medical community to think about surgical treatment of thin diabetics. Analysis of surgical literature indicate MGB/OAGB as a procedure with greatest succes in thin diabetics. AP Vojvodina is European region with highest rate of incidence and mortality of DMT2. 2/3rd patients have inadequate conservative treatment of DMT2 in Novi Sad, capital of AP Vojvodina. As a bariatric and metabolic surgical centre, we offer MGB/OAGB to patients and there is no response from endocrinologists. With Dr Robert Rutledge, the inventor of MGB/OAGB, we started in 2016 and done for 8 patients. Results are favourable with stopped insulin therapy on 7 th day in all patients.

Biography :

Miroslav D Ilic has completed his PhD from University of Novi Sad in the field of Hepato/Biliary/Pacreatic Surgery. He is the Director of Centre for Esophageal and Laparoscopic Surgery in Clinic for Thoracic Surgery, Institute for Lung Diseases in Sr. Kamenica. He is the founder of Alma Mons course in Bariatric Surgery. He published 25 papers in literature as well as several books in Surgery.

E-mail: drmiroslavilic@gmail.com